nejm tirzepatide In the SURMOUNT-1 trial (published in in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor 📢 New in NEJM: Tirzepatide

Glutathione injections deliver the antioxidant directly into the muscle, allowing for faster absorption and higher bioavailability compared to oral supplements, which can be broken down in the digestive tract

It is also helpful to take it with a small amount of food

Celebrities are known to use glutathione injections to maintain their flawless, radiant skin with the injection being highly effective for those requiring a slightly lighter tone

Lorenzo Biasio and Gloria Skibba discuss the integration of Ypsomeds Net Zero Program into its self-injection platforms and explain how YpsoMate 1 and 2.25 mL autoinjectors have been redesigned to achieve a lower carbon footprint